| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $602.2M | -8.7% |
| Cost of Revenue | $363.7M | -9.9% |
| Gross Profit | $238.5M | -6.9% |
| R&D Expense | $18.7M | -21.5% |
| SG&A Expense | $132.1M | +9.9% |
| Operating Income | $14.7M | -84.4% |
| Pre-tax Income | -$26.3M | -195.2% |
| Income Tax | -$3.0M | -136.0% |
| Net Income | -$23.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $56.1M | +36.5% |
| Accounts Receivable | $36.1M | -25.3% |
| Inventory | $192.5M | +0.1% |
| Current Assets | $297.3M | -0.0% |
| Total Assets | $1.13B | -5.8% |
| Current Liabilities | $95.2M | +1.5% |
| Long-term Debt | $552.6M | -5.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $46.9M | -46.8% |
| Capital Expenditures | $6.8M | +14.7% |
| Investing Cash Flow | $2.0M | +145.4% |
| Financing Cash Flow | -$34.6M | +49.9% |
| Free Cash Flow | $40.1M | -51.2% |
| -221.1% |
| EPS (Basic) | -$0.20 | -225.0% |
| EPS (Diluted) | -$0.20 | -225.0% |
| Total Liabilities |
| $712.2M |
| -6.6% |
| Stockholders' Equity | $421.2M | -4.5% |